(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 down 1.7%, FTSE 250 off 1.3%
Jan 29 (Reuters) - The FTSE 100 dropped on Friday and was
set to record its worst week since October as stalled vaccine
rollouts and lockdowns to curb the spread of contagious new
coronavirus strains kept investors from jumping into riskier
assets.
The blue-chip FTSE 100 index .FTSE dropped 1.7%, with
energy .FTNMX0530 and mining .FTNMX1770 stocks being top
drags for the week, while the mid-cap index .FTMC fell 1.3%.
The benchmark indices were also set to fall for the month,
with the mid-cap index set to record its worst monthly loss
since September.
Drugmaker AstraZeneca AZN.L fell 3.6% for the week and was
one of the top drags on the blue-chip index as a tussle with the
European Union on vaccine rollouts continued to weigh on the
stock.
The European Union's contract with AstraZeneca for its
COVID-19 vaccine contains binding orders, EU Commision Head
Ursula von der Leyen said, demanding a plausible explanation
from the drugmaker for delivery hold-ups. British online fashion retailer Boohoo BOOH.L fell 1.5%
after it confirmed on Friday it was in exclusive talks with the
administrators of Philip Green's collapsed Arcadia group over
the purchase of the Dorothy Perkins, Wallis and Burton
brands.